Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00671112
Title Everolimus and Bortezomib in Treating Patients With Relapsed or Refractory Lymphoma
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Brian Hill, MD, PhD
Indications
Therapies
Age Groups: adult
Covered Countries USA


No variant requirements are available.